Concepts (287)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Membrane Fusion | 16 | 2016 | 29 | 2.860 |
Why?
|
| Cell Membrane | 12 | 2018 | 90 | 2.280 |
Why?
|
| Membrane Lipids | 11 | 2016 | 15 | 2.230 |
Why?
|
| Models, Biological | 11 | 2016 | 326 | 1.660 |
Why?
|
| Lipid Bilayers | 11 | 2016 | 57 | 1.600 |
Why?
|
| Viral Fusion Proteins | 7 | 2020 | 15 | 1.490 |
Why?
|
| Models, Chemical | 7 | 2016 | 44 | 1.310 |
Why?
|
| Membrane Microdomains | 5 | 2008 | 10 | 1.160 |
Why?
|
| Virus Internalization | 7 | 2021 | 19 | 1.140 |
Why?
|
| HIV-1 | 7 | 2011 | 236 | 1.130 |
Why?
|
| HIV Envelope Protein gp41 | 5 | 2011 | 12 | 0.960 |
Why?
|
| Membrane Fluidity | 4 | 2008 | 7 | 0.900 |
Why?
|
| Intestinal Mucosa | 3 | 2011 | 192 | 0.820 |
Why?
|
| Light | 4 | 2011 | 81 | 0.800 |
Why?
|
| Models, Molecular | 6 | 2011 | 84 | 0.770 |
Why?
|
| Algorithms | 9 | 2008 | 377 | 0.760 |
Why?
|
| Viral Envelope Proteins | 6 | 2021 | 15 | 0.710 |
Why?
|
| Cholesterol | 4 | 2018 | 64 | 0.710 |
Why?
|
| Membrane Proteins | 5 | 2019 | 171 | 0.700 |
Why?
|
| Membrane Potentials | 3 | 2010 | 185 | 0.650 |
Why?
|
| Ebolavirus | 2 | 2016 | 6 | 0.640 |
Why?
|
| Protein Folding | 4 | 2009 | 21 | 0.630 |
Why?
|
| Image Interpretation, Computer-Assisted | 6 | 2011 | 67 | 0.620 |
Why?
|
| Precancerous Conditions | 2 | 2010 | 25 | 0.610 |
Why?
|
| Erythrocytes | 2 | 2018 | 20 | 0.610 |
Why?
|
| beta-Cyclodextrins | 1 | 2018 | 3 | 0.600 |
Why?
|
| Breast Neoplasms | 4 | 2018 | 409 | 0.540 |
Why?
|
| Cells | 1 | 2016 | 3 | 0.520 |
Why?
|
| Viruses | 1 | 2016 | 6 | 0.520 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2016 | 7 | 0.510 |
Why?
|
| Cell Line | 9 | 2015 | 280 | 0.510 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2016 | 11 | 0.500 |
Why?
|
| Semliki forest virus | 2 | 2007 | 3 | 0.500 |
Why?
|
| Mutation | 5 | 2016 | 353 | 0.490 |
Why?
|
| Animals | 16 | 2021 | 3780 | 0.480 |
Why?
|
| Thermodynamics | 5 | 2018 | 43 | 0.470 |
Why?
|
| Water | 2 | 2011 | 32 | 0.450 |
Why?
|
| Cell Fusion | 4 | 2010 | 10 | 0.450 |
Why?
|
| Hydrogen-Ion Concentration | 9 | 2016 | 149 | 0.450 |
Why?
|
| Viral Proteins | 2 | 2013 | 13 | 0.450 |
Why?
|
| Mechanical Phenomena | 1 | 2013 | 25 | 0.440 |
Why?
|
| Protein Structure, Secondary | 3 | 2011 | 21 | 0.430 |
Why?
|
| Endosomes | 3 | 2021 | 8 | 0.420 |
Why?
|
| Gene Products, env | 4 | 2009 | 14 | 0.410 |
Why?
|
| Peptide Fragments | 2 | 2011 | 77 | 0.410 |
Why?
|
| Protein Transport | 2 | 2019 | 32 | 0.400 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 4 | 2016 | 12 | 0.390 |
Why?
|
| Microfluidics | 1 | 2011 | 7 | 0.390 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 1 | 2011 | 3 | 0.370 |
Why?
|
| Fiber Optic Technology | 1 | 2011 | 7 | 0.370 |
Why?
|
| Epithelium | 1 | 2011 | 29 | 0.370 |
Why?
|
| Endocytosis | 1 | 2011 | 17 | 0.360 |
Why?
|
| Liposomes | 5 | 2016 | 13 | 0.360 |
Why?
|
| Carcinoma in Situ | 1 | 2010 | 10 | 0.360 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2004 | 169 | 0.350 |
Why?
|
| Anti-HIV Agents | 1 | 2011 | 71 | 0.350 |
Why?
|
| HEK293 Cells | 5 | 2021 | 67 | 0.340 |
Why?
|
| Porosity | 3 | 2016 | 61 | 0.340 |
Why?
|
| Humans | 27 | 2021 | 28395 | 0.330 |
Why?
|
| CD4 Antigens | 4 | 2005 | 29 | 0.330 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2009 | 19 | 0.330 |
Why?
|
| Colonic Neoplasms | 2 | 2011 | 61 | 0.330 |
Why?
|
| Prions | 1 | 2009 | 8 | 0.330 |
Why?
|
| Scattering, Radiation | 6 | 2011 | 37 | 0.330 |
Why?
|
| Stochastic Processes | 4 | 2011 | 13 | 0.320 |
Why?
|
| HIV | 1 | 2009 | 43 | 0.320 |
Why?
|
| Photometry | 1 | 2008 | 1 | 0.310 |
Why?
|
| Colorectal Neoplasms | 1 | 2010 | 112 | 0.310 |
Why?
|
| Protein Conformation | 8 | 2009 | 74 | 0.310 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2008 | 9 | 0.310 |
Why?
|
| Computer Simulation | 5 | 2011 | 199 | 0.300 |
Why?
|
| Amino Acid Sequence | 7 | 2011 | 160 | 0.300 |
Why?
|
| Molecular Sequence Data | 7 | 2011 | 199 | 0.300 |
Why?
|
| Virion | 4 | 2020 | 14 | 0.290 |
Why?
|
| Brain Mapping | 2 | 1998 | 150 | 0.280 |
Why?
|
| Artificial Intelligence | 2 | 2007 | 35 | 0.280 |
Why?
|
| Databases, Protein | 1 | 2007 | 2 | 0.280 |
Why?
|
| Sequence Analysis, Protein | 1 | 2007 | 5 | 0.280 |
Why?
|
| Brain | 3 | 2004 | 1663 | 0.280 |
Why?
|
| Biophysics | 1 | 2007 | 36 | 0.280 |
Why?
|
| Proteins | 1 | 2007 | 67 | 0.270 |
Why?
|
| Lipid Peroxides | 1 | 2006 | 2 | 0.270 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2006 | 199 | 0.270 |
Why?
|
| Flow Cytometry | 3 | 2016 | 116 | 0.260 |
Why?
|
| Spectrum Analysis | 1 | 2006 | 8 | 0.260 |
Why?
|
| Energy Transfer | 3 | 2004 | 5 | 0.260 |
Why?
|
| COS Cells | 5 | 2021 | 43 | 0.250 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2005 | 16 | 0.250 |
Why?
|
| Colitis | 1 | 2006 | 37 | 0.250 |
Why?
|
| Receptors, Chemokine | 1 | 2005 | 9 | 0.250 |
Why?
|
| Influenza A virus | 4 | 2019 | 15 | 0.250 |
Why?
|
| Diagnostic Imaging | 1 | 2006 | 80 | 0.240 |
Why?
|
| Ultrasonography, Mammary | 4 | 2008 | 10 | 0.240 |
Why?
|
| Nonlinear Dynamics | 1 | 2004 | 13 | 0.230 |
Why?
|
| Lassa virus | 2 | 2021 | 4 | 0.230 |
Why?
|
| Lipids | 3 | 2011 | 52 | 0.230 |
Why?
|
| Orthomyxoviridae | 2 | 2001 | 2 | 0.220 |
Why?
|
| Temperature | 4 | 2007 | 66 | 0.220 |
Why?
|
| Sphingolipids | 1 | 2002 | 3 | 0.210 |
Why?
|
| Pattern Recognition, Automated | 3 | 2008 | 8 | 0.210 |
Why?
|
| Molecular Conformation | 3 | 2008 | 10 | 0.200 |
Why?
|
| Rats | 5 | 2011 | 678 | 0.200 |
Why?
|
| Antiviral Agents | 2 | 2020 | 71 | 0.200 |
Why?
|
| Lassa Fever | 1 | 2021 | 2 | 0.190 |
Why?
|
| Monoglycerides | 1 | 2021 | 2 | 0.190 |
Why?
|
| Lysophospholipids | 1 | 2021 | 3 | 0.190 |
Why?
|
| Sensitivity and Specificity | 4 | 2011 | 517 | 0.180 |
Why?
|
| Colicins | 4 | 1995 | 4 | 0.180 |
Why?
|
| Elasticity | 3 | 2015 | 31 | 0.180 |
Why?
|
| DNA Virus Infections | 1 | 2020 | 4 | 0.170 |
Why?
|
| RNA Virus Infections | 1 | 2020 | 4 | 0.170 |
Why?
|
| RNA Viruses | 1 | 2020 | 4 | 0.170 |
Why?
|
| Salicylates | 1 | 2020 | 6 | 0.170 |
Why?
|
| DNA Viruses | 1 | 2020 | 6 | 0.170 |
Why?
|
| Fluorescent Dyes | 4 | 2010 | 38 | 0.170 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2011 | 37 | 0.160 |
Why?
|
| Ultrasonography | 1 | 2001 | 243 | 0.160 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 25 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 1 | 2018 | 119 | 0.150 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 102 | 0.150 |
Why?
|
| Models, Statistical | 2 | 2008 | 129 | 0.140 |
Why?
|
| Patch-Clamp Techniques | 2 | 2016 | 114 | 0.140 |
Why?
|
| Protein Structure, Tertiary | 2 | 2009 | 60 | 0.130 |
Why?
|
| Ion Channels | 3 | 1995 | 234 | 0.130 |
Why?
|
| Membranes | 1 | 2016 | 9 | 0.130 |
Why?
|
| Hemagglutinins | 1 | 1996 | 1 | 0.130 |
Why?
|
| Cathepsins | 1 | 2016 | 4 | 0.130 |
Why?
|
| Stress, Mechanical | 2 | 2008 | 162 | 0.130 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 58 | 0.130 |
Why?
|
| Blotting, Western | 1 | 2016 | 148 | 0.130 |
Why?
|
| Signal Transduction | 1 | 2018 | 447 | 0.120 |
Why?
|
| Detergents | 2 | 2007 | 4 | 0.120 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 362 | 0.120 |
Why?
|
| Exocytosis | 2 | 1993 | 4 | 0.120 |
Why?
|
| Mice | 4 | 2008 | 1461 | 0.110 |
Why?
|
| Structure-Activity Relationship | 2 | 2004 | 40 | 0.110 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 2013 | 5 | 0.110 |
Why?
|
| Time Factors | 2 | 2010 | 1490 | 0.110 |
Why?
|
| Surface Tension | 2 | 2015 | 3 | 0.110 |
Why?
|
| Phantoms, Imaging | 2 | 2010 | 39 | 0.110 |
Why?
|
| Antigens, Differentiation | 1 | 2013 | 10 | 0.110 |
Why?
|
| Escherichia coli Proteins | 2 | 2009 | 12 | 0.100 |
Why?
|
| Reproducibility of Results | 4 | 2008 | 733 | 0.100 |
Why?
|
| Kinetics | 3 | 2009 | 194 | 0.100 |
Why?
|
| Virus Replication | 2 | 2020 | 51 | 0.100 |
Why?
|
| Amino Acid Substitution | 2 | 2011 | 25 | 0.100 |
Why?
|
| Data Interpretation, Statistical | 2 | 2006 | 83 | 0.100 |
Why?
|
| Viscosity | 1 | 2011 | 9 | 0.100 |
Why?
|
| Friction | 1 | 2011 | 20 | 0.100 |
Why?
|
| Diffusion | 1 | 2011 | 25 | 0.100 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2011 | 1 | 0.090 |
Why?
|
| Protein Stability | 1 | 2011 | 5 | 0.090 |
Why?
|
| Entropy | 1 | 2011 | 5 | 0.090 |
Why?
|
| Biomechanical Phenomena | 1 | 2013 | 645 | 0.090 |
Why?
|
| Drug Synergism | 1 | 2011 | 40 | 0.090 |
Why?
|
| Drug Resistance, Viral | 1 | 2011 | 14 | 0.090 |
Why?
|
| Escherichia coli | 3 | 2009 | 56 | 0.090 |
Why?
|
| Peptides | 2 | 2009 | 103 | 0.090 |
Why?
|
| Rabbits | 1 | 2011 | 185 | 0.090 |
Why?
|
| HeLa Cells | 3 | 2005 | 42 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 2 | 2006 | 79 | 0.090 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2010 | 33 | 0.090 |
Why?
|
| Membrane Transport Proteins | 1 | 2011 | 57 | 0.090 |
Why?
|
| Fluorescence | 1 | 2010 | 10 | 0.090 |
Why?
|
| Plasmids | 2 | 2009 | 47 | 0.090 |
Why?
|
| Electricity | 1 | 2010 | 9 | 0.090 |
Why?
|
| Early Diagnosis | 1 | 2010 | 67 | 0.090 |
Why?
|
| Biopsy | 1 | 2011 | 220 | 0.090 |
Why?
|
| Mutagenesis | 1 | 2009 | 12 | 0.080 |
Why?
|
| Acyltransferases | 1 | 2009 | 5 | 0.080 |
Why?
|
| Electrophysiology | 2 | 2007 | 103 | 0.080 |
Why?
|
| Image Enhancement | 2 | 2008 | 49 | 0.080 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2009 | 87 | 0.080 |
Why?
|
| Intracellular Membranes | 2 | 2007 | 22 | 0.080 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 213 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 3 | 1998 | 341 | 0.080 |
Why?
|
| Radio Waves | 3 | 2008 | 9 | 0.080 |
Why?
|
| Wettability | 1 | 2008 | 1 | 0.080 |
Why?
|
| Receptors, CCR5 | 2 | 2005 | 14 | 0.080 |
Why?
|
| Potassium | 2 | 2002 | 66 | 0.080 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2006 | 34 | 0.070 |
Why?
|
| Reference Values | 2 | 1998 | 194 | 0.070 |
Why?
|
| Carcinoma, Ductal | 1 | 2008 | 5 | 0.070 |
Why?
|
| Receptors, CXCR4 | 2 | 2005 | 17 | 0.070 |
Why?
|
| Electric Capacitance | 1 | 2007 | 6 | 0.070 |
Why?
|
| Cell Membrane Permeability | 1 | 2007 | 58 | 0.070 |
Why?
|
| Permeability | 1 | 2007 | 120 | 0.070 |
Why?
|
| Information Storage and Retrieval | 1 | 2007 | 3 | 0.070 |
Why?
|
| Sequence Alignment | 1 | 2007 | 21 | 0.070 |
Why?
|
| Anisotropy | 1 | 2007 | 47 | 0.070 |
Why?
|
| Phosphatidylethanolamines | 1 | 2006 | 2 | 0.070 |
Why?
|
| Photobleaching | 1 | 2006 | 2 | 0.070 |
Why?
|
| Sphingomyelins | 1 | 2006 | 5 | 0.070 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2006 | 9 | 0.070 |
Why?
|
| Neoplasm Staging | 1 | 2008 | 371 | 0.070 |
Why?
|
| Electrochemistry | 1 | 2006 | 44 | 0.070 |
Why?
|
| Oxidation-Reduction | 1 | 2006 | 65 | 0.070 |
Why?
|
| HIV Fusion Inhibitors | 1 | 2005 | 2 | 0.060 |
Why?
|
| Gene Deletion | 1 | 2005 | 42 | 0.060 |
Why?
|
| Cryoultramicrotomy | 1 | 2004 | 1 | 0.060 |
Why?
|
| Biomedical Engineering | 2 | 2001 | 5 | 0.060 |
Why?
|
| User-Computer Interface | 1 | 2004 | 20 | 0.060 |
Why?
|
| Female | 4 | 2018 | 15704 | 0.060 |
Why?
|
| HIV Infections | 1 | 2009 | 488 | 0.060 |
Why?
|
| Trypan Blue | 1 | 2002 | 1 | 0.050 |
Why?
|
| Hydrogen Bonding | 1 | 2002 | 3 | 0.050 |
Why?
|
| Zinc | 1 | 2002 | 47 | 0.050 |
Why?
|
| Hemorrhoids | 1 | 2001 | 1 | 0.050 |
Why?
|
| Micelles | 1 | 2001 | 1 | 0.050 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2001 | 1 | 0.050 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2001 | 3 | 0.050 |
Why?
|
| Vero Cells | 1 | 2020 | 8 | 0.040 |
Why?
|
| DNA Replication | 1 | 2020 | 10 | 0.040 |
Why?
|
| DNA, Viral | 1 | 2020 | 40 | 0.040 |
Why?
|
| Point Mutation | 1 | 1999 | 27 | 0.040 |
Why?
|
| Interferons | 1 | 2019 | 8 | 0.040 |
Why?
|
| A549 Cells | 1 | 2019 | 10 | 0.040 |
Why?
|
| Optical Imaging | 1 | 2019 | 5 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 14 | 0.040 |
Why?
|
| Artifacts | 1 | 1998 | 33 | 0.040 |
Why?
|
| Biological Transport | 3 | 1995 | 40 | 0.040 |
Why?
|
| Astrocytes | 1 | 2020 | 150 | 0.040 |
Why?
|
| Species Specificity | 1 | 1998 | 42 | 0.040 |
Why?
|
| Models, Neurological | 1 | 1998 | 25 | 0.040 |
Why?
|
| Lysophosphatidylcholines | 1 | 1997 | 8 | 0.040 |
Why?
|
| Isotope Labeling | 1 | 1997 | 3 | 0.030 |
Why?
|
| Physical Phenomena | 1 | 2016 | 3 | 0.030 |
Why?
|
| Receptors, Virus | 1 | 2015 | 5 | 0.030 |
Why?
|
| Phosphatidylcholines | 1 | 2015 | 6 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 53 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2015 | 72 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2015 | 106 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2005 | 31 | 0.030 |
Why?
|
| Male | 3 | 2001 | 15269 | 0.030 |
Why?
|
| Mast Cells | 1 | 1993 | 18 | 0.030 |
Why?
|
| Pulmonary Adenomatosis, Ovine | 1 | 2013 | 2 | 0.030 |
Why?
|
| Jaagsiekte sheep retrovirus | 1 | 2013 | 2 | 0.030 |
Why?
|
| Cricetulus | 1 | 2013 | 11 | 0.030 |
Why?
|
| Antigens, Viral | 1 | 2013 | 9 | 0.030 |
Why?
|
| Sheep | 1 | 2013 | 19 | 0.030 |
Why?
|
| Cricetinae | 1 | 2013 | 37 | 0.030 |
Why?
|
| ROC Curve | 2 | 2003 | 144 | 0.020 |
Why?
|
| Rhodamines | 1 | 1991 | 5 | 0.020 |
Why?
|
| Video Recording | 1 | 1991 | 35 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 1990 | 78 | 0.020 |
Why?
|
| Gene Products, gag | 1 | 2005 | 3 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2005 | 23 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2005 | 23 | 0.020 |
Why?
|
| Kidney | 1 | 2005 | 175 | 0.010 |
Why?
|
| Quality Control | 1 | 2003 | 32 | 0.010 |
Why?
|
| Proctoscopy | 1 | 2001 | 1 | 0.010 |
Why?
|
| Proctoscopes | 1 | 2001 | 1 | 0.010 |
Why?
|
| Arteries | 1 | 2001 | 16 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2003 | 492 | 0.010 |
Why?
|
| Ligation | 1 | 2001 | 38 | 0.010 |
Why?
|
| Fibrocystic Breast Disease | 1 | 2001 | 5 | 0.010 |
Why?
|
| Fibroadenoma | 1 | 2001 | 6 | 0.010 |
Why?
|
| Suture Techniques | 1 | 2001 | 157 | 0.010 |
Why?
|
| Chlorpromazine | 1 | 1999 | 4 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1999 | 10 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 1999 | 38 | 0.010 |
Why?
|
| Phenotype | 1 | 1999 | 310 | 0.010 |
Why?
|
| Fluoresceins | 1 | 1997 | 6 | 0.010 |
Why?
|
| Fluorometry | 1 | 1997 | 5 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1997 | 17 | 0.010 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1997 | 3 | 0.010 |
Why?
|
| Gangliosides | 1 | 1997 | 6 | 0.010 |
Why?
|
| Cobalt | 1 | 1997 | 113 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 1995 | 11 | 0.010 |
Why?
|
| Protein Binding | 1 | 1995 | 132 | 0.010 |
Why?
|
| Freeze Fracturing | 1 | 1993 | 1 | 0.010 |
Why?
|
| Peritoneal Cavity | 1 | 1993 | 2 | 0.010 |
Why?
|
| Cytoplasmic Granules | 1 | 1993 | 5 | 0.010 |
Why?
|
| Cell Degranulation | 1 | 1993 | 6 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1993 | 67 | 0.010 |
Why?
|
| Electric Conductivity | 1 | 1993 | 71 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2001 | 4851 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 1993 | 435 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1991 | 8 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 1991 | 12 | 0.010 |
Why?
|
| Papain | 1 | 1990 | 1 | 0.010 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 1990 | 3 | 0.010 |
Why?
|
| Glucosides | 1 | 1990 | 2 | 0.010 |
Why?
|
| Acrylamides | 1 | 1990 | 3 | 0.010 |
Why?
|
| Adult | 1 | 2001 | 8097 | 0.000 |
Why?
|
| Middle Aged | 1 | 2001 | 9250 | 0.000 |
Why?
|
| Aged | 1 | 2001 | 9256 | 0.000 |
Why?
|